A randomized placebo-controlled trial of delayed-release dimethyl fumarate in patients with relapsing-remitting multiple sclerosis from East Asia and other countries

被引：0
作者：
Takahiko Saida
Takashi Yamamura
Takayuki Kondo
Jang Yun
Minhua Yang
Jie Li
Lalitha Mahadavan
Bing Zhu
Sarah I. Sheikh
机构：
[1] Kyoto Min-iren Central Hospital,Kansai Multiple Sclerosis Centre
[2] National Center Hospital,NCNP
[3] Kansai Medical University Medical Center,undefined
[4] Biogen,undefined
[5] Sanofi,undefined
[6] Faculty of Pharmaceutical Medicine,undefined
来源：
BMC Neurology | / 19卷
关键词：
Delayed-release dimethyl fumarate; East Asia; Japan; Magnetic resonance imaging; Multiple sclerosis; Randomized clinical trial;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [21] Acyclovir treatment of relapsing-remitting multiple sclerosis - A randomized, placebo-controlled, double-blind study
    Lycke, J
    Svennerholm, B
    Hjelmquist, E
    Frisen, L
    Badr, G
    Andersson, M
    Vahlne, A
    Andersen, O
    JOURNAL OF NEUROLOGY, 1996, 243 (03) : 214 - 224
  • [22] Effectiveness of delayed-release dimethyl fumarate on patient-reported outcomes and clinical measures in patients with relapsing-remitting multiple sclerosis in a real-world clinical setting: PROTEC
    Berger, T.
    Brochet, B.
    Brambilla, L.
    Giacomini, P. S.
    Montalban, X.
    Salgado, A. Vasco
    Su, R.
    Bretagne, A.
    MULTIPLE SCLEROSIS JOURNAL-EXPERIMENTAL TRANSLATIONAL AND CLINICAL, 2019, 5 (04)
  • [23] Cost-effectiveness of delayed-release dimethyl fumarate for the treatment of relapsing forms of multiple sclerosis in the United States
    Mauskopf, Josephine
    Fay, Monica
    Iyer, Ravi
    Sarda, Sujata
    Livingston, Terrie
    JOURNAL OF MEDICAL ECONOMICS, 2016, 19 (04) : 432 - 442
  • [24] The effects of ginger supplementation on common gastrointestinal symptoms in patients with relapsing-remitting multiple sclerosis: a double-blind randomized placebo-controlled trial
    Foshati, Sahar
    Poursadeghfard, Maryam
    Heidari, Zahra
    Amani, Reza
    BMC COMPLEMENTARY MEDICINE AND THERAPIES, 2023, 23 (01)
  • [25] The effects of ginger supplementation on common gastrointestinal symptoms in patients with relapsing-remitting multiple sclerosis: a double-blind randomized placebo-controlled trial
    Sahar Foshati
    Maryam Poursadeghfard
    Zahra Heidari
    Reza Amani
    BMC Complementary Medicine and Therapies, 23
  • [26] Effects of Acupuncture on Cognitive Functions in Patients with Relapsing-Remitting Multiple Sclerosis: A Randomized Controlled Trial
    Khodaie, Faezeh
    Saeedi, Roghayyeh
    Soleimany, Ghazaleh
    Sahraian, Mohammad Ali
    Kazemi, Amir Hooman
    Moghadasi, Abdorreza Naser
    Zhao, Bai-xiao
    CHINESE JOURNAL OF INTEGRATIVE MEDICINE, 2025,
  • [27] Sustained Effect of Delayed-Release Dimethyl Fumarate in Newly Diagnosed Patients with Relapsing–Remitting Multiple Sclerosis: 6-Year Interim Results From an Extension of the DEFINE and CONFIRM Studies
    Gold R.
    Giovannoni G.
    Phillips J.T.
    Fox R.J.
    Zhang A.
    Marantz J.L.
    Neurology and Therapy, 2016, 5 (1) : 45 - 57
  • [28] The budget impact of introducing delayed-release dimethyl fumarate for treatment of relapse-remitting multiple sclerosis in Canada
    Dorman, Emily
    Kansal, Anuraag R.
    Sarda, Sujata
    JOURNAL OF MEDICAL ECONOMICS, 2015, 18 (12) : 1085 - 1091
  • [29] Glatiramer acetate in combination with minocycline in patients with relapsing-remitting multiple sclerosis: results of a Canadian, multicenter, double-blind, placebo-controlled trial
    Metz, L. M.
    Li, D.
    Traboulsee, A.
    Myles, M. L.
    Duquette, P.
    Godin, J.
    Constantin, M.
    Yong, V. W.
    MULTIPLE SCLEROSIS, 2009, 15 (10): : 1183 - 1194
  • [30] Probiotic supplementation and systemic inflammation in relapsing-remitting multiple sclerosis: A randomized, double-blind, placebo-controlled trial (vol 16, 901846, 2022)
    Rahimlou, Mehran
    Nematollahi, Shima
    Husain, Durdana
    Banaei-Jahromi, Nasrin
    Majdinasab, Nastaran
    Hosseini, Seyed Ahmad
    FRONTIERS IN NEUROSCIENCE, 2022, 16
12345